Novalead

NovaLead is a drug discovery research company focused on discovering new indications for generic drugs. Through its proprietary technology platform, NovaLead's drug repositioning approach aims to identify new biological targets for generics, thereby uncovering new indications. This method differs significantly from traditional line extension strategies. NovaLead’s business development and outsourced research services are managed by its wholly-owned subsidiary, Novalead Pharma Inc.